Amneal (AMRX) EVP nets stock from RSU vesting and tax withholdings

Rhea-AI Filing Summary

Amneal Pharmaceuticals Executive Vice President Nikita Shah reported multiple equity award vestings and related share withholdings. On March 3, 2026, performance-based restricted stock units granted in 2023 were certified above target, vesting at 200% of the targeted number and settling into an equal number of Class A shares.

Across March 3–4, 2026, Shah acquired Class A Common Stock through exercises and conversions of restricted stock units and performance-based units, while a portion of the resulting shares was automatically disposed of at prices around $13.30 per share to satisfy tax withholding obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Nikita

(Last) (First) (Middle)

C/O AMNEAL PHARMACEUTICALS, INC.

400 CROSSING BLVD.

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amneal Pharmaceuticals, Inc. [ AMRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/03/2026		M		36,232(1)	A	(2)	182,635	D
Class A Common Stock	03/03/2026		F		18,502(3)	D	$13.31	164,133	D
Class A Common Stock	03/03/2026		M		45,871(1)	A	(2)	210,004	D
Class A Common Stock	03/03/2026		F		22,982(3)	D	$13.31	187,022	D
Class A Common Stock	03/03/2026		M		23,544(1)	A	(2)	210,566	D
Class A Common Stock	03/03/2026		F		11,796(3)	D	$13.31	198,770	D
Class A Common Stock	03/03/2026		M		366,972	A	(4)	565,742	D
Class A Common Stock	03/03/2026		F		183,853(5)	D	$13.31	381,889	D
Class A Common Stock	03/04/2026		M		35,880(1)	A	(2)	417,769	D
Class A Common Stock	03/04/2026		F		17,976(3)	D	$13.3	399,793	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/03/2026		M			36,232	(6)	(6)	Class A Common Stock	36,232	$0	0	D
Restricted Stock Units	(2)	03/03/2026		M			45,871	(7)	(7)	Class A Common Stock	45,871	$0	45,872	D
Restricted Stock Units	(2)	03/03/2026		M			23,544	(8)	(8)	Class A Common Stock	23,544	$0	70,634	D
Performance-Based Restricted Stock Units	(4)	03/03/2026		M			366,972	(4)	(4)	Class A Common Stock	366,972	$0	0	D
Restricted Stock Units	(2)	03/04/2026		M			35,880	(9)	(9)	Class A Common Stock	35,880	$0	71,760	D

Explanation of Responses:

1. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

3. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

4. Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.

5. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.

6. On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

7. On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

8. On March 3, 2025, the reporting person was granted 94,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

9. On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Denis Butkovic, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AMRX executive Nikita Shah report?

Nikita Shah reported vesting and settlement of restricted stock units and performance-based units into Amneal Class A Common Stock, along with share dispositions used to cover tax withholding obligations. These transactions reflect equity compensation mechanics rather than open market stock purchases or sales.

How were performance-based RSUs for AMRX’s Nikita Shah determined and vested?

Performance-based restricted stock units granted on March 3, 2023 vested based on Amneal’s Class A Common Stock achieving specified average closing prices over a three-year period. They were certified as meeting a performance threshold that produced vesting at 200% of the targeted number of units.

Did Amneal EVP Nikita Shah sell AMRX shares in the open market?

The reported dispositions are coded as tax-withholding events, where shares of Amneal Class A Common Stock were withheld or delivered to satisfy tax obligations on vesting. They are described as payments of tax liability, not discretionary open market sales of shares.

What does a Form 4 code F mean in Nikita Shah’s AMRX filing?

In this context, transaction code F means shares of Amneal Class A Common Stock were disposed of to pay tax withholding on vested restricted stock units or performance-based units. The filing notes these were payments of exercise price or tax liability by delivering securities.

How does RSU vesting affect Nikita Shah’s AMRX share ownership?

When restricted stock units and performance-based units vest, they convert into Amneal Class A Common Stock, increasing the executive’s share holdings. However, the gross shares issued are reduced by shares withheld for taxes, so the net increase is smaller than the total units that vested.